1
|
Nasirshalal M, Panahi M, Javanshir N, Salmani H. Identification of a novel heterozygous mutation in the MITF gene in an Iranian family with Waardenburg syndrome type II using next-generation sequencing. J Clin Lab Anal 2021; 35:e23792. [PMID: 33942382 PMCID: PMC8183924 DOI: 10.1002/jcla.23792] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 03/29/2021] [Accepted: 04/06/2021] [Indexed: 12/30/2022] Open
Abstract
Background Waardenburg syndrome (WS) is a genetically heterogeneous syndrome with both autosomal recessive and dominant inheritance. WS causes skin and iris pigmentation accumulation and sensorineural hearing loss, in varying degrees. There are four WS types with different characteristics. WS1 and WS2 are the most common and have a dominant inheritance. WS2 is caused by mutations in the microphthalmia‐associated transcription factor (MITF) gene. Methods An Iranian couple with hearing loss was recruited in the present study. First, they were screened for GJB2 and GJB6 gene mutations, and then whole‐exome sequencing 100X was performed along with bioinformatics analysis. Results A novel pathogenic heterozygous mutation, c.425T>A; p.L142Ter, was detected in the MITF gene's exon 4. Bioinformatics analysis predicted c.425T>A; p.L142Ter as a possible pathogenic variation. It appears that the mutated transcript level declines through nonsense‐mediated decay. It probably created a significantly truncated protein and lost conserved and functional domains like basic helix‐loop‐helix‐zipper proteins. Besides, the variant was utterly co‐segregated with the disease within the family. Conclusions We investigated an Iranian family with congenital hearing loss and identified a novel pathogenic variant c.425T>A; p. L142Ter in the MITF gene related to WS2. This variant is a nonsense mutation, probably leading to a premature stop codon. Our data may be beneficial in upgrading gene mutation databases and identifying WS2 causes.
Collapse
Affiliation(s)
- Mahzad Nasirshalal
- Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Mohammad Panahi
- Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Nahid Javanshir
- Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tabriz, Iran
| | - Hamzeh Salmani
- Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Liu Q, Cheng J, Lu Y, Zhou J, Wang L, Yang C, Yang G, Yang H, Cao J, Zhang Z, Sun Y. The clinical and genetic research of Waardenburg syndrome type I and II in Chinese families. Int J Pediatr Otorhinolaryngol 2020; 130:109806. [PMID: 31812001 DOI: 10.1016/j.ijporl.2019.109806] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Revised: 10/31/2019] [Accepted: 11/26/2019] [Indexed: 12/25/2022]
Abstract
OBJECTIVE Waardenburg Syndrome (WS) is a neurocristopathy with an autosomal dominant mode of inheritance and highly genetic heterogeneity. To date, mutations of PAX3, SOX10, MITF, EDNRB, EDN3 and SNAI2 have been implicated in the pathogenesis of WS. In this study, we aimed to identify pathogenic genes among WS families and to analyze the pathogenic relationship between genotypes and phenotypes. METHODS In this study, all six families studied were from Hubei province, China.WS patients underwent screening for all deafness genes including PAX3, SOX10, MITF, EDNRB, EDN3 and SNAI2 using Massively Parallel Sequencing (MPS) and validation of mutations using Sanger sequencing. RESULTS Clinical evaluation revealed prominent phenotypic variability in Hubei WS patients. Two WS1 families and four WS2 families were diagnosed in six families. Sensorineural hearing loss was the most common, followed by iris pigmentary abnormality. Molecular genetic analysis of the WS genes for six families revealed five novel heterozygous mutations. Two mutations occurred in the PAX3 gene: one nonsense mutation c.667C > T(p.Arg223Ter) and one missense mutation c.220C > T(p.Arg74Cys).One missense mutation c.331T > C (p.Phe111Leu) and one nonsense mutation c.346C > T(p.Gln116Ter) were detected in the SOX10 gene. Two mutations were detected in the MITF gene: one splice site mutation c.859-1G > A and one nonsense mutation c.859G > T(p.Glu287Ter). Among them, the mutations (SOX10 c.331T > C and MITF c.859G > T) were de novo mutations. CONCLUSION In this study, six mutations were found to be associated with the phenotype of patients. Our data helped illuminate the phenotypic and genotypic spectrum of WS in Hubei province and could have implications for the genetic counseling of WS in Hubei province.
Collapse
Affiliation(s)
- Qin Liu
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Jing Cheng
- Medical Genetics Center, The First Affiliated Hospital, Army Medical University, Chongqing, 400038, China
| | - Yu Lu
- Medical Genetics Center, The First Affiliated Hospital, Army Medical University, Chongqing, 400038, China
| | - Jia Zhou
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Li Wang
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Changliang Yang
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Guang Yang
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Hui Yang
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Jingyuan Cao
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Zhao Zhang
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China
| | - Yi Sun
- Department of Otorhinolaryngology, General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan, 430000, China; Southern Medical University, Guangzhou, 510000, China.
| |
Collapse
|
3
|
Kim MW, Jang DH, Kang J, Lee S, Joo SY, Jang JH, Cho EH, Choi YC, Lee JH. Novel Mutation (c.8725T>C) in Two Siblings With Late-Onset LAMA2-Related Muscular Dystrophy. Ann Lab Med 2019; 37:359-361. [PMID: 28445022 PMCID: PMC5409025 DOI: 10.3343/alm.2017.37.4.359] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2016] [Revised: 01/04/2017] [Accepted: 03/13/2017] [Indexed: 12/03/2022] Open
Affiliation(s)
- Min Wook Kim
- Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Dae Hyun Jang
- Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
| | - Jun Kang
- Department of Hospital Pathology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Seungok Lee
- Department of Laboratory Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Sun Young Joo
- Department of Orthopaedic Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Ja Hyun Jang
- Green Cross Genome, Yongin, Korea.,Green Cross Laboratories, Yongin, Korea
| | | | - Young Chul Choi
- Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jung Hwan Lee
- Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| |
Collapse
|
4
|
Boudjadi S, Chatterjee B, Sun W, Vemu P, Barr FG. The expression and function of PAX3 in development and disease. Gene 2018; 666:145-157. [PMID: 29730428 DOI: 10.1016/j.gene.2018.04.087] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2017] [Revised: 04/26/2018] [Accepted: 04/27/2018] [Indexed: 12/27/2022]
Abstract
The PAX3 gene encodes a member of the PAX family of transcription factors that is characterized by a highly conserved paired box motif. The PAX3 protein is a transcription factor consisting of an N-terminal DNA binding domain (containing a paired box and homeodomain) and a C-terminal transcriptional activation domain. This protein is expressed during development of skeletal muscle, central nervous system and neural crest derivatives, and regulates expression of target genes that impact on proliferation, survival, differentiation and motility in these lineages. Germline mutations of the murine Pax3 and human PAX3 genes cause deficiencies in these developmental lineages and result in the Splotch phenotype and Waardenburg syndrome, respectively. Somatic genetic rearrangements that juxtapose the PAX3 DNA binding domain to the transcriptional activation domain of other transcription factors deregulate PAX3 function and contribute to the pathogenesis of the soft tissue cancers alveolar rhabdomyosarcoma and biphenotypic sinonasal sarcoma. The wild-type PAX3 protein is also expressed in other cancers related to developmental lineages that normally express this protein and exerts phenotypic effects related to its normal developmental role.
Collapse
Affiliation(s)
- Salah Boudjadi
- Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
| | | | - Wenyue Sun
- Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
| | - Prasantha Vemu
- Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
| | - Frederic G Barr
- Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.
| |
Collapse
|
5
|
Whole-exome sequencing analysis of Waardenburg syndrome in a Chinese family. Hum Genome Var 2017; 4:17027. [PMID: 28690861 PMCID: PMC5489998 DOI: 10.1038/hgv.2017.27] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Revised: 04/25/2017] [Accepted: 04/26/2017] [Indexed: 11/08/2022] Open
Abstract
Waardenburg syndrome (WS) is a dominantly inherited, genetically heterogeneous auditory-pigmentary syndrome characterized by non-progressive sensorineural hearing loss and iris discoloration. By whole-exome sequencing (WES), we identified a nonsense mutation (c.598C>T) in PAX3 gene, predicted to be disease causing by in silico analysis. This is the first report of genetically diagnosed case of WS PAX3 c.598C>T nonsense mutation in Chinese ethnic origin by WES and in silico functional prediction methods.
Collapse
|
6
|
Oh JY, Do HJ, Lee S, Jang JH, Cho EH, Jang DH. Identification of a Heterozygous SPG11 Mutation by Clinical Exome Sequencing in a Patient With Hereditary Spastic Paraplegia: A Case Report. Ann Rehabil Med 2016; 40:1129-1134. [PMID: 28119845 PMCID: PMC5256329 DOI: 10.5535/arm.2016.40.6.1129] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2015] [Accepted: 04/08/2016] [Indexed: 12/13/2022] Open
Abstract
Next-generation sequencing, such as whole-genome sequencing, whole-exome sequencing, and targeted panel sequencing have been applied for diagnosis of many genetic diseases, and are in the process of replacing the traditional methods of genetic analysis. Clinical exome sequencing (CES), which provides not only sequence variation data but also clinical interpretation, aids in reaching a final conclusion with regards to genetic diagnosis. Sequencing of genes with clinical relevance rather than whole exome sequencing might be more suitable for the diagnosis of known hereditary disease with genetic heterogeneity. Here, we present the clinical usefulness of CES for the diagnosis of hereditary spastic paraplegia (HSP). We report a case of patient who was strongly suspected of having HSP based on her clinical manifestations. HSP is one of the diseases with high genetic heterogeneity, the 72 different loci and 59 discovered genes identified so far. Therefore, traditional approach for diagnosis of HSP with genetic analysis is very challenging and time-consuming. CES with TruSight One Sequencing Panel, which enriches about 4,800 genes with clinical relevance, revealed compound heterozygous mutations in SPG11. One workflow and one procedure can provide the results of genetic analysis, and CES with enrichment of clinically relevant genes is a cost-effective and time-saving diagnostic tool for diseases with genetic heterogeneity, including HSP.
Collapse
Affiliation(s)
- Ja-Young Oh
- Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
| | - Hyun Jung Do
- Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
| | - Seungok Lee
- Department of Laboratory Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
| | - Ja-Hyun Jang
- Green Cross Laboratories, Yongin, Korea.; Green Cross Genome, Yongin, Korea
| | | | - Dae-Hyun Jang
- Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
| |
Collapse
|
7
|
Duque GA, Ramírez Cheyne J, Saldarriaga Gil W. Síndrome de Waardenburg tipo 1 en gemelos monocigóticos y su familia. REVISTA DE LA FACULTAD DE MEDICINA 2016. [DOI: 10.15446/revfacmed.v64n2.50290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
<p>El síndrome de Waardenburg (SW) es un trastorno genético poco frecuente con una incidencia de 1 por 40000 habitantes. Es originado por mutaciones en múltiples genes como PAX3, MITF, SNAI2 y SOX10; estas alteraciones genéticas ocasionan anomalías en el desarrollo de los tejidos derivados de las células de la cresta neural y producen hallazgos fenotípicos característicos como iris de color azul claro o heterocromía del iris, poliosis, sordera neurosensorial, entre otros. El objetivo de este artículo es reportar a la literatura un caso poco frecuente de gemelos monocigóticos con hallazgos clínicos típicos de síndrome de Waardenburg tipo 1 con fenotipo diferente entre ellos, su madre y su abuela. Aquí también se establece la importancia del índice W en el diagnóstico y clasificación de este síndrome. Los hallazgos aquí reportados muestran la variabilidad de las manifestaciones fenotípicas del síndrome de Waardenburg tipo 1 dentro de una familia y especialmente en gemelos monocigóticos, lo que se ha explicado por la expresión variable de genes específicos o por la interacción de ellos con genes modificadores. Cabe resaltar que los gemelos fueron expuestos a alcohol en el primer trimestre del embarazo, por lo cual se propone que la expresión variable del SW fue influenciada por exposiciones a agentes medioambientales.</p>
Collapse
|